Latest Board And Management Changes News

Manhattan Gold Limited has reshaped its board and management team following the full acquisition of the Hook Lake Project, signalling a strategic pivot towards advancing this key asset.

Mamba Exploration Limited has agreed to acquire a 70% interest in the Meeka East Gold Project in Western Australia’s Murchison Goldfield, supported by a $2 million capital raise to fund exploration activities.

Raptor Metals Ltd has completed its takeover of Raptor Resources Limited, marking a strategic pivot to copper exploration in Canada’s Bathurst Mining Camp, backed by a fresh A$5 million capital raise.

Oceana Metals Limited has completed trenching at its Solonopole Project in Brazil and is progressing technical reviews of its Australian assets, while a strategic rebrand and board refresh signal a new phase for the company.

Premier1 Lithium has significantly expanded its gold-in-soil anomaly at the Rochefort Prospect and secured $2.17 million in fresh capital to accelerate exploration at its Western Australian projects.

Altech Batteries Limited has undergone a significant board and management reshuffle following a shareholder-led challenge, appointing new leadership while reaffirming its strategic focus on advanced battery technologies.

Avenira Limited reports significant progress at its Wonarah Phosphate Project, alongside key board and management changes, while maintaining a solid cash position at the end of Q3 2025.

Artemis Resources has reported promising early drilling results at its Karratha Gold-Copper Project alongside key tenement grants and agreements at its Cassowary Exploration Project, supported by a recent $4.9 million capital raise.

Tamboran Resources has reported record natural gas flow rates from its Shenandoah South 2H sidetrack well and initiated the largest drilling program ever seen in the Beetaloo Basin, alongside securing key approvals for gas sales.

Following its recent sale transaction, MPR Australia Limited announces significant board resignations alongside continued leadership under CEO Nathan Wise, signaling a strategic transition phase.

NeuroScientific Biopharmaceuticals reported a $1.85 million loss for FY25, driven by reduced R&D incentives and increased development costs following its acquisition of StemSmart™ technology. The company is advancing clinical programs, including a Special Access Scheme for Crohn’s disease.

Bastion Minerals has resumed ASX trading under a refreshed leadership team, announcing a JORC-compliant resource at its ICE Copper-Gold Project and completing multiple capital raises to support its renewed exploration focus.